Diabetes tech company recalls some Dexcom G7 sensors 26 May 2026 The Therapeutic Goods Administration has issued a notice that AA-Med Pty Ltd is recalling two lots of Dexcom G7 sensors. The lots affected are 1725204004 and 1725069002. These lots were identified for disposal and destruction in the USA due to incomplete sterilisation and deployment failure during testing. The devices from both lots were stolen during the disposal process, and sold to third parties via unauthorised supply channels.As the supply channels for these lots cannot be established, the risk of some devices reaching the Australian market cannot be excluded. No Dexcom G7 sensors received through the NDSS will be impacted by the recall.The TGA advised that if you have any of the affected products, immediately discontinue use and dispose of them. For more information, please refer to the market action alert on the TGA website.
News 9 September 2026 Changes to FreeStyle Libre 3 Plus access coming soon Australians living with type 1 diabetes will soon have access to Abbott Diabetes Care’s FreeStyle Libre 3 Plus continuous glucose monitor (CGM) as a standalone sensor, without needing an automatic insulin device (AID) connection. Continue Reading
News 7 September 2026 Urgent Product Correction: Dexcom G7 iOS App AMSL Diabetes, a Dexcom company, has issued an urgent Product Correction for the Dexcom G7 iOS App version 2.12 following... Continue Reading
Blog 7 September 2026 5 tips for eating out with type 1 diabetes (without the stress) In our season launch of Life on the Level podcast, dietitian (and T1D legend) Nicole Rizk shares her five tips for eating and drinking out without the stress. Continue Reading